[New antineoplastic agents].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D011809:Quinones / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D011809:Quinones; D003561:Cytarabine; D001215:Asparaginase; D003630:Daunorubicin